Respect des Standards consolidés dans des rapports d’essais (CONSORT) lignes directrices pour la déclaration des résultats de sécurité dans les essais des cannabinoïdes pour la douleur chronique : protocole pour un examen systématique.

Published by Michael on

Related Posts

Medical

Long-term effectiveness and safety of medical cannabis administered through the metered-dose Syqe Inhaler

Pain Rep. 2022 May 17;7(3):e1011. doi: 10.1097/PR9.0000000000001011. eCollection 2022 May-Jun. ABSTRACT INTRODUCTION: Preliminary clinical studies on medical cannabis (MC) treatment using the Syqe Inhaler showed short-term effectiveness and safety at very low and precise doses Read more…

Medical

The effects of COVID-19 on poisonings in the paediatric emergency department

Paediatr Child Health. 2022 Apr 28;27(Suppl 1):S4-S8. doi: 10.1093/pch/pxab100. eCollection 2022 Jun. ABSTRACT OBJECTIVES: The purpose of this study is to describe the impact of the pandemic on poisoning in children under 18 years presenting Read more…

Medical

Cannabinoids modulate proliferation, differentiation, and migration signaling pathways in oligodendrocytes

Eur Arch Psychiatry Clin Neurosci. 2022 May 27. doi: 10.1007/s00406-022-01425-5. Online ahead of print. ABSTRACT Cannabinoid signaling, mainly via CB1 and CB2 receptors, plays an essential role in oligodendrocyte health and functions. However, the specific Read more…

error: Content is protected !!